missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PATL1 (aa 360-457) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (94%), Rat (94%). This recombinant protein control fragment may be used for blocking experiments. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
RNA-binding protein involved in deadenylation-dependent decapping of mRNAs, leading to the degradation of mRNAs. Acts as a scaffold protein that connects deadenylation and decapping machinery. Required for cytoplasmic mRNA processing body (P-body) assembly. In case of infection, required for translation and replication of hepatitis C virus (HCV).
Specifications
Specifications
| Accession Number | Q86TB9 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 219988 |
| Name | Human PATL1 (aa 360-457) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AV312086; hPat1b; OK/KNS-cl0.5; PAT1 homolog 1, processing body mRNA decay factor; Pat1b; PAT1-like protein 1; PATL1; protein associated with topoisomerase II homolog 1; protein associated with topoisomerase II homolog 1 (yeast); protein PAT1 homolog 1; Protein PAT1 homolog b; RGD1305514 |
| Common Name | PATL1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction